Growth Capitalist (https://growthcapitalist.com/tag/biotech/page/67/)
Paulson Capital Corporation (PLCC) announced that it has raised $11,000,000 in a Common Stock transaction. Issuer counsel was Holland & Knight. Note that concurrently with this Placement, the Company completed a reverse merger with Variation Biotechnologies (US), Inc. Further details have yet to be disclosed. via PlacementTracker.
Immunomedics, Inc. (IMMU) announced that it has raised $30,150,000 in a CMPO/Overnight transaction. The common stock was sold at $3.35 per share, an approximate 19% discount to the market price ($4.14) of IMMU at deal announcement. Wells Fargo Securities and Jefferies & Company acted as Joint Book-Running Managers on the transaction. Underwriter counsel was Goodwin Procter and issuer counsel was DLA Piper. The transaction is expected to close on May 7, 2014.
Alimera Sciences Inc. (ALIM) announced that it has raised $10,000,000 in a Non-Convertible Debentures transaction. The securities accrue interest at a rate of 10.9%. A series of 285,016 Warrants with an exercise price of $6.14 per share was issued to the investor in this transaction. The investor was Hercules Technology Growth Capital. The transaction closed on April 25, 2014.
Vical Inc. (VICL) announced that it has secured up to $25,000,000 in an ATM (At the Market) transaction with Brinson Patrick Securities Corporation. The purchase price is the prevailing market price at the time of the Draw Down Notice. Placement Agent counsel was Ropes & Gray and issuer counsel was Cooley. An agreement was reached on April 15, 2014. via PlacementTracker.
